iVisit vs enov8tiveChatMe
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
iVisit
Connect with your healthcare provider through secure text messaging, video calls, and asynchronous question-based visits. This telemedicine solution facilitates efficient communication between patients and providers from your mobile device.
- Secure text messaging
- Video visits
- Asynchronous question-based visits
- HIPAA compliant
- Provider-patient communication
Read full descriptionHide full description
GenieMD iVisit makes connecting with your Provider quicker and easier from the convenience of your mobile device. iVisit offers a telemedicine solution that allows Providers and Patients to communicate more efficiently by using secure, HIPAA compliant text messaging, video visits and question-based asynchronous visits.
enov8tiveChatMe
This medical practice communication app offers real-time, HIPAA-compliant messaging and video conferencing. It integrates seamlessly with other solutions to boost office productivity and ensure secure communication with end-to-end encryption.
- Real-time messaging integration
- HIPAA compliant
- End-to-end encryption
- Boosts office productivity
- File and image attachments
- Call and video conferencing
- Group discussion capabilities
Read full descriptionHide full description
enov8tiveChatMe is the perfect complementing app to enov8tive’s Suite of Solutions that are truly and fully Integrated, One-Stop-Shop Suite of Solutions for all of your practice’s business needs. enov8tiveChatMe offers the foremost technology solutions for business practices who want excellence and efficiency every time. enov8tiveChatMe values key strategic partnerships with its associates, clients, and partners, hence, the substantial precedence on pleasant and excellent experiences at every step. enov8tiveChatMe app clients enjoy the following: · Desktop and Mobile App Real-time Integration of Messaging or Communication · HIPAA Compliant Messaging App · Promotes Seamless Health Record Management · Chat in Confidence with its End-to-End Encryption · Boosts Office Productivity · Chat and Messaging Capabilities · File and Image Attachment Capabilities · Call and Video Conferencing Within the Practice · Group Discussion Capabilities · Compatible with all enov8tive’s Platforms
Screenshots
Verdict
The clearest difference is ads: enov8tiveChatMe at none against iVisit's shown. enov8tiveChatMe also leads on rating (5.0 vs 4.5) and monetization model (free vs ad-supported). iVisit's advantage is ratings volume (65 vs 1) and iOS requirement (12.0 vs 14.0). On price, update cadence, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
enov8tiveChatMe holds the better App Store score, 5.0 against 4.5. That said, the two scores are not equally well evidenced: iVisit has 65 ratings behind it against 1, so its average is the more settled of the two.
iVisit ships an update every 2 weeks, enov8tiveChatMe weekly. The most recent releases landed on November 16, 2026 and November 17, 2026 respectively.
| Parameter | iVisit | enov8tiveChatMe |
|---|---|---|
| Price | Free | Free |
| Rating | 4.5 (65 ratings) | 5.0 (1 ratings) — better |
| Positive reviews | 85.2% of reviews | — |
| Number of ratings | 65 — better | 1 |
| Update frequency | Every 2 weeks | Weekly — better |
| Ads | Yes | No — better |
| In-app purchases | No | No |
| Monetization | Ad-supported | Free — better |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 — better | 14.0 |
| Further details — not scored | ||
| Size | 151 MB | 114 MB |
| Age rating | 17+ | 17+ |
| Developer | GenieMD, Inc. | enov8tive |
Customer experience
iVisit
enov8tiveChatMe
In-app purchases
iVisit
No in-app purchases
enov8tiveChatMe
No in-app purchases









